AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.27B |
| 2 |
Visa
V
|
+$459M |
| 3 |
Nike
NKE
|
+$410M |
| 4 |
Etsy
ETSY
|
+$311M |
| 5 |
Gen Digital
GEN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$606M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$492M |
| 3 |
Procter & Gamble
PG
|
+$389M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$310M |
| 5 |
IQVIA
IQV
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.23% |
| 2 | Healthcare | 14.38% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 12.81% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRDX
2501
DELISTED
Surmodics
SRDX
| $1.07M | ﹤0.01% |
19,721
+3,320
| +20% | +$182K |
|
|
JKS
2502
JinkoSolar
JKS
$793M
| $1.07M | ﹤0.01% |
+19,043
| New | +$727K |
|
2503
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
| $1.07M | ﹤0.01% |
6,141
+2,205
| +56% | +$382K |
|
2504
Caleres
CAL
$431M
| $1.06M | ﹤0.01% |
38,873
+15,400
| +66% | +$386K |
|
2505
Peabody Energy
BTU
$2.6B
| $1.06M | ﹤0.01% |
133,700
+45,300
| +51% | +$268K |
|
2506
Collegium Pharmaceutical
COLL
$1.15B
| $1.06M | ﹤0.01% |
44,744
| – | – |
|
|
VRTV
2507
DELISTED
VERITIV CORPORATION
VRTV
| $1.06M | ﹤0.01% |
+17,227
| New | +$900K |
|
2508
Northern Oil and Gas
NOG
$2.3B
| $1.05M | ﹤0.01% |
+50,700
| New | +$826K |
|
2509
Simulations Plus
SLP
$369M
| $1.05M | ﹤0.01% |
19,172
+3,910
| +26% | +$224K |
|
2510
OptimizeRx
OPRX
$114M
| $1.05M | ﹤0.01% |
+17,000
| New | +$865K |
|
|
CNR
2511
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $1.05M | ﹤0.01% |
+57,600
| New | +$927K |
|
2512
National Healthcare
NHC
$3.53B
| $1.04M | ﹤0.01% |
14,936
| – | – |
|
2513
Omeros
OMER
$857M
| $1.04M | ﹤0.01% |
69,900
| – | – |
|
|
AERI
2514
DELISTED
Aerie Pharmaceuticals
AERI
| $1.03M | ﹤0.01% |
64,500
+5,400
| +9% | +$92.6K |
|
|
CCRN
2515
DELISTED
Cross Country Healthcare
CCRN
| $1.03M | ﹤0.01% |
62,515
-3,370
| -5% | -$51.4K |
|
|
GAN
2516
DELISTED
GAN Ltd
GAN
| $1.03M | ﹤0.01% |
62,801
+31,901
| +103% | +$562K |
|
2517
Theravance Biopharma
TBPH
$874M
| $1.03M | ﹤0.01% |
70,735
| – | – |
|
|
DMTK
2518
DELISTED
DermTech, Inc. Common Stock
DMTK
| $1.03M | ﹤0.01% |
+24,700
| New | +$1.01M |
|
2519
Axogen
AXGN
$2.27B
| $1.02M | ﹤0.01% |
47,300
-3,000
| -6% | -$60.6K |
|
2520
ProPetro Holding
PUMP
$1.36B
| $1.02M | ﹤0.01% |
111,341
-8,800
| -7% | -$91.2K |
|
2521
Arcturus Therapeutics
ARCT
$164M
| $1.02M | ﹤0.01% |
30,100
| – | – |
|
2522
Par Pacific Holdings
PARR
$4.31B
| $1.02M | ﹤0.01% |
60,490
| – | – |
|
2523
Photronics
PLAB
$1.79B
| $1.02M | ﹤0.01% |
76,874
+18,460
| +32% | +$241K |
|
2524
BioLife Solutions
BLFS
$1.53B
| $1.01M | ﹤0.01% |
22,800
+5,100
| +29% | +$180K |
|
2525
Douglas Dynamics
PLOW
$1.02B
| $1.01M | ﹤0.01% |
24,800
-9,589
| -28% | -$421K |
|
Similar funds
AllianceBernstein's Q2 2021 Portfolio in Review
As of Q2 2021, AllianceBernstein held 3,558 positions worth $249B, up 9.2% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AllianceBernstein's Q2 2021 filing shows 327 new, 1,436 increased, 1,300 reduced and 241 closed positions. Its largest new stake was Coinbase: 547,649 shares worth $139M. The largest sale was Regeneron Pharmaceuticals, an estimated $606M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q2 2021 buy was Coinbase: 547,649 shares worth $139M.
- AllianceBernstein added most to Amazon in Q2 2021, an estimated $1.27B increase.
- AllianceBernstein's biggest Q2 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $606M.
- AllianceBernstein fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $43.3M.
- AllianceBernstein's ten largest holdings make up 24% of its $249B portfolio in Q2 2021.
- AllianceBernstein opened 327 new positions and closed 241 in Q2 2021.
- AllianceBernstein's portfolio value rose 9.2% quarter-over-quarter to $249B.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.